Analytical Data
-
Gene name
C1orf194
- Application
-
Alternative Names
C1orf194；C1orf194；Cilia- and flagella-associated Protein 276
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q5T5A4
-
Expression Region
1-169aa
-
AA Sequence
MPPTRDPFQQ PTLDNDDSYL GELRASKKLP YKNPTHLAQQ QEPWSRLNST PTITSMRRDA YYFDPEIPKD DLDFRLAALY NHHTGTFKNK SEILLNQKTT QDTYRTKIQF PGEFLTPPTP PITFLANIRH WINPKKESIH SIQGSIVSPH TAATNGGYSR KKDGGFFST
-
Molecular Weight
19.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C1orf194, also known as Chromosome 1 Open Reading Frame 194, is a protein-coding gene located on chromosome 1, which has garnered interest due to its potential role in various biological processes and disease pathways. Research into C1orf194 has been relatively sparse, yet emerging studies suggest it may be implicated in cellular functions such as cell proliferation, differentiation, and apoptosis. The re-combinant expression of C1orf194 can facilitate the investigation of its structural and functional properties, thereby revealing insights into its biological significance. Additionally, understanding the role of C1orf194 in the context of certain diseases, particularly cancers and metabolic disorders, could lead to novel therapeutic approaches. The production of recombinant C1orf194 protein allows for the development of assays to study its interactions with other cellular proteins and pathways, potentially unveiling its mechanistic involvement in disease. This research could contribute to a greater understanding of the gene’s functional repertoire and significance, paving the way for further investigations into how C1orf194 might be targeted for therapeutic interventions. Overall, the study of C1orf194 through recombinant protein technology holds promise for advancing knowledge in both basic biology and clinical applications.
